1. Home
  2. ARTNA vs IPSC Comparison

ARTNA vs IPSC Comparison

Compare ARTNA & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Artesian Resources Corporation

ARTNA

Artesian Resources Corporation

HOLD

Current Price

$31.50

Market Cap

344.1M

Sector

Utilities

ML Signal

HOLD

Logo Century Therapeutics Inc.

IPSC

Century Therapeutics Inc.

HOLD

Current Price

$2.21

Market Cap

399.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARTNA
IPSC
Founded
1905
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Water Supply
Medicinal Chemicals and Botanical Products
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
344.1M
399.0M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
ARTNA
IPSC
Price
$31.50
$2.21
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$4.25
AVG Volume (30 Days)
32.6K
1.1M
Earning Date
05-12-2026
05-14-2026
Dividend Yield
3.96%
N/A
EPS Growth
N/A
91.30
EPS
N/A
N/A
Revenue
N/A
$109,164,000.00
Revenue This Year
$7.82
N/A
Revenue Next Year
$3.54
N/A
P/E Ratio
$15.23
N/A
Revenue Growth
N/A
1556.76
52 Week Low
$30.50
$0.44
52 Week High
$36.19
$2.97

Technical Indicators

Market Signals
Indicator
ARTNA
IPSC
Relative Strength Index (RSI) 42.60 45.84
Support Level $31.40 $1.87
Resistance Level $33.89 $2.67
Average True Range (ATR) 0.74 0.16
MACD -0.06 -0.02
Stochastic Oscillator 3.40 6.25

Price Performance

Historical Comparison
ARTNA
IPSC

About ARTNA Artesian Resources Corporation

Artesian Resources Corp operates as a holding company with a focus on water distribution and wastewater services. Its regulated utility segment includes subsidiaries providing water and wastewater services in Delaware, Maryland, and Pennsylvania. Water distribution spans residential, commercial, industrial, and municipal sectors, while wastewater services are offered in Sussex County, Delaware. The company also engages in non-utility businesses, offering service line protection plans, engineering services, and contract operations for water and wastewater systems. The regulated utility segment constitutes the portion of the company's operations, subject to regulations by Delaware, Maryland, and Pennsylvania.

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.

Share on Social Networks: